文献速递免疫规划

火鸡疱疹病毒疫苗对超强毒马立克氏病病毒诱导的脾细胞变化保护有限

Herpesvirus of Turkeys (HVT) vaccine confers limited protection against the cellular changes induced by very virulent plus Marek's disease virus (vv + MDV) strains in commercial meat-type chickens.
PubMed 文献 · Vaccine · 2026-07-14

本研究评估重组火鸡疱疹病毒(rHVT)疫苗标准剂量(SD)或高剂量(HD)对超强毒plus(vv+)马立克氏病病毒(MDV)株686诱导的商品肉鸡脾细胞损伤的保护作用。结果显示两种剂量均部分保护脾细胞对ConA的增殖反应,但至感染后25天均未限制脾脏病毒DNA载量,对脾脏免疫表型改变的保护不理想,高剂量无额外获益。

要点

  • rHVT疫苗SD和HD均保护686诱导的脾细胞对ConA增殖反应下降。
  • 两种剂量在6 dpi仅轻微降低脾脏686复制,25 dpi未限制DNA载量。
  • 疫苗未防止活脾细胞、B细胞及KUL01+MHC-IIhigh+ APC数量下降。

核心结论

  • rHVT疫苗接种对vv+ MDV 686诱导的脾脏免疫表型变化提供部分保护,但高剂量无额外获益。

研究设计与样本

  • 研究在商品肉鸡中评估rHVT疫苗标准剂量或高剂量对vv+ MDV株686诱导脾细胞损伤的保护。

主要发现

  • rHVT-SD和rHVT-HD均保护686诱导的脾细胞对ConA增殖反应下降。
  • 两种剂量在6 dpi轻微降低脾脏686复制但无显著性,25 dpi未限制686 DNA载量。
  • 25 dpi时疫苗未防止活脾细胞、B细胞或KUL01+MHC-IIhigh+ APC数量下降。
  • rHVT-SD/686组活脾细胞和B细胞百分比略高于686感染组,rHVT-HD/686组仅B细胞数值增加。
  • 两种剂量均降低活化CD4+ T细胞百分比和γδ+ T细胞百分比;活化CD8α+ T细胞仅HD组显著降低,活化CD8β+ T细胞仅SD组降低。

临床怎么用

  • rHVT疫苗可部分缓解vv+ MDV诱导的脾细胞功能损伤,但不应依赖高剂量增强保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Very virulent plus (vv+) Marek's disease virus (MDV) strains are highly immunosuppressive and cause marked alterations in splenic immune cell populations in commercial meat-type (MT) chickens, even in the presence of maternal antibodies. In this study, we evaluated the protection provided by a recombinant herpesvirus of turkeys (rHVT) vaccine delivered at either a standard dose (SD) or a high dose (HD) against splenocyte damage induced by the vv + MDV strain 686 in MT chickens. Results showed that both rHVT-SD and rHVT-HD protected against the 686-induced reduction in splenocyte lymphoproliferative responses to concanavalin A (ConA) ex vivo and modestly, albeit not significantly, reduced 686 replication in the spleen at 6 days post-infection (dpi). However, by 25 dpi, neither vaccine dose limited the 686 DNA load in the spleen. Protection against splenic immunophenotypic alterations at 25 dpi was suboptimal; neither rHVT-SD nor rHVT-HD prevented the reduction in the number of live splenocytes, B cells, or KUL01+MHC-IIhigh+ APCs. However, modest improvements were observed; the rHVT-SD/686 group showed slightly higher percentages of live splenocytes and B cells than the 686-infected group, whereas the rHVT-HD/686 group exhibited a numerical increase only in B cells. Furthermore, rHVT vaccination influenced the percentage of activated T cells. Both rHVT-SD and rHVT-HD vaccinations decreased the percentage of activated CD4+ T cells. The percentage of activated CD8α+ T cells was also reduced in both vaccine groups, but the reduction was significant only in the HD group, whereas the proportion of activated CD8β+ T cells decreased only in the SD-vaccinated group. In addition, both vaccine doses reduced the percentage of γδ+ T cells. Overall, our findings demonstrate that vaccination with rHVT provided partial protection against vv + MDV 686-induced immunophenotypic changes in the spleen, with no added benefit from using a higher rHVT-vaccine dose.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Khaled N, Gaghan C, Fares AM, et al. Herpesvirus of Turkeys (HVT) vaccine confers limited protection against the cellular changes induced by very virulent plus Marek's disease virus (vv + MDV) strains in commercial meat-type chickens. Vaccine. 2026. PMID: 42447734. doi:10.1016/j.vaccine.2026.128921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。